Joshua Allen, PhD, VP Research & Development, talks about the potential of ONC201 to treat glioblastoma multiforme at the Brain Tumor Biotech Summit 2015 in New York City on May 29 2015.
Business Development
© Copyright 2016 Oncoceutics, Inc. All Rights Reserved.